To verify whether LCN2 was downregulated at the protein level in esophageal cancer cells, we treated cancer cells with different concentrations of CUDC-907 and performed western blot analysis, showing that LCN2 was considerably decreased at the protein level (Fig. 4b). This evidence concerns the gene LCN2 and cancer.